Author:
Zhang Xiaomin,Yang Jieli,Chen Sai,Liu Chang,Wang Zhenhua,Ren Hefei,Zhou Lin
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Hematology
Reference40 articles.
1. Spaan I, Raymakers RA, van de Stolpe A, Peperzak V (2018) Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential. J Hematol Oncol 11(1):67
2. Gerecke C, Fuhrmann S, Strifler S, Schmidt-Hieber M, Einsele H, Knop S (2016) The diagnosis and treatment of multiple myeloma. Dtsch Arztebl Int 113(27–28):470–476
3. Jagannath S (2008) Treatment of patients with myeloma with comorbid conditions: considerations for the clinician. Clin Lymphoma Myeloma 8(Suppl 4):S149–S156
4. Chou YS, Yang CF, Chen HS, Yang SH, Yu YB, Hong YC et al (2012) Pre-existing diabetes mellitus in patients with multiple myeloma. Eur J Haematol 89(4):320–327
5. Wu W, Merriman K, Nabaah A, Seval N, Seval D, Lin H et al (2014) The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma. Br J Cancer 111(3):628–636